It has been shown that cancer initiating cells inhibited T cell proliferation in vitro via their membrane-associated IL-4 and IL-4R, while blocking IL-4-impaired tumor growth and stimulating antitumor T cell effectors [139]. Here, IL4 is linked to neoplasm.